Found: 8
Select item for more details and to access through your institution.
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 overexpression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
- Published in:
- Orphanet Journal of Rare Diseases, 2014, v. 9, n. 1, p. 282, doi. 10.1186/s13023-014-0201-x
- By:
- Publication type:
- Article
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
P1‐061: DOUBLE‐BLIND ARGUMENT FOR A SYNERGISTIC THERAPEUTIC EFFECT OF A FIXED LOW‐DOSE COMBINATION OF ACAMPROSATE AND BACLOFEN IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P292, doi. 10.1016/j.jalz.2018.06.063
- By:
- Publication type:
- Article
A COMBINATION OF ACAMPROSATE AND BACLOFEN (PXT864) SYNERGIZES WITH STANDARDS OF CARE FOR THE TREATMENT OF ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P948, doi. 10.1016/j.jalz.2017.06.1860
- By:
- Publication type:
- Article
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.
- Published in:
- Scientific Reports, 2015, p. 16084, doi. 10.1038/srep16084
- By:
- Publication type:
- Article
Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis.
- Published in:
- Journal of Neuroscience Research, 2020, v. 98, n. 12, p. 2435, doi. 10.1002/jnr.24714
- By:
- Publication type:
- Article
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats.
- Published in:
- Journal of Neuroscience Research, 2020, v. 98, n. 10, p. 1933, doi. 10.1002/jnr.24679
- By:
- Publication type:
- Article
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A).
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0209752
- By:
- Publication type:
- Article